Viard I, Hall S H, Jaillard C, Berthelon M C, Saez J M
Inserm U 307, Hôpital Debrousse, Lyon, France.
Endocrinology. 1992 Mar;130(3):1193-200. doi: 10.1210/endo.130.3.1311231.
Previous work has shown that corticotropin (ACTH) and angiotensin-II (A-II), in addition to their acute steroidogenic effects, exert long-term influences on adrenal cell differentiated function, stimulatory or inhibitory, respectively. Certain nuclear proto-oncogenes have been implicated in the regulation of gene expression in many cell systems. We have investigated the effects of ACTH and A-II on the levels of c-fos, c-jun, and jun-B messenger RNAs (mRNAs), in bovine and ovine (OAC) adrenal fasciculata cells. In both cell types ACTH produced time- (maximum at 1 h) and dose-dependent (ED50 congruent to 10(-12) M) increase in c-fos (2- to 4-fold) and jun-B (10- to 20-fold) mRNA levels but did not affect c-jun. The concentrations required to induce half-maximal mRNA accumulation and cortisol production were similar. A-II also produced a dose-dependent increase in c-fos and jun-B mRNAs but also in c-jun in both cell types, despite the fact that OAC are resistant to the steroidogenic action of the hormone. The stimulatory effects of A-II on c-fos mRNA were higher than those produced by ACTH, whereas the effects on jun-B were similar but ACTH abolished (OAC) or decreased (bovine adrenal fasciculata cells) the stimulatory effects of A-II on c-jun mRNA. The effects of ACTH and A-II on cortisol production and proto-oncogene mRNAs were in part mimicked by 8 Bromo-cAMP and the phorbol ester phorbol-12-myristate-13 acetate plus calcium ionophore A23187, respectively. In the presence of cycloheximide, which blocks the steroidogenic effects of both hormones, proto-oncogene mRNAs were superinduced by both hormones. This result, together with the fact that dexamethasone failed to affect the mRNA levels suggests that the stimulatory effects of ACTH and A-II on proto-oncogene expression were not related to an autocrine/intracrine action of cortisol. Taken together, these findings show that the proto-oncogene mRNAs in normal adrenal cells are regulated by ACTH and A-II, acting through different intracellular pathways. They also demonstrate differential responsiveness of the Jun family to both hormones. Thus, the opposite long-term action of ACTH and A-II on adrenal cell differentiated function could be mediated by its different initial effects on proto-oncogene expression, in particular in the members of the Jun family.
以往的研究表明,促肾上腺皮质激素(ACTH)和血管紧张素-II(A-II)除了具有急性促肾上腺皮质激素生成作用外,还分别对肾上腺细胞的分化功能产生长期的刺激或抑制作用。某些核原癌基因参与了许多细胞系统中基因表达的调控。我们研究了ACTH和A-II对牛和羊(OAC)肾上腺束状带细胞中c-fos、c-jun和jun-B信使核糖核酸(mRNA)水平的影响。在这两种细胞类型中,ACTH均使c-fos(2至4倍)和jun-B(10至20倍)的mRNA水平呈时间依赖性(1小时达到最大值)和剂量依赖性(半数有效剂量相当于10⁻¹² M)增加,但不影响c-jun。诱导半数最大mRNA积累和皮质醇产生所需的浓度相似。A-II也使两种细胞类型中的c-fos和jun-B mRNA呈剂量依赖性增加,但也使c-jun增加,尽管OAC对该激素的促肾上腺皮质激素生成作用具有抗性。A-II对c-fos mRNA的刺激作用高于ACTH,而对jun-B的作用相似,但ACTH消除了(OAC)或降低了(牛肾上腺束状带细胞)A-II对c-jun mRNA的刺激作用。ACTH和A-II对皮质醇产生和原癌基因mRNA的作用部分分别被8-溴环磷腺苷和佛波酯佛波醇-12-肉豆蔻酸酯-13-乙酸盐加钙离子载体A23187模拟。在存在放线菌酮(它阻断了两种激素的促肾上腺皮质激素生成作用)的情况下,两种激素均使原癌基因mRNA超诱导。这一结果,连同地塞米松未能影响mRNA水平这一事实,表明ACTH和A-II对原癌基因表达的刺激作用与皮质醇的自分泌/胞内分泌作用无关。综上所述,这些发现表明,正常肾上腺细胞中的原癌基因mRNA受ACTH和A-II调控,通过不同的细胞内途径发挥作用。它们还证明了Jun家族对两种激素的反应性存在差异。因此,ACTH和A-II对肾上腺细胞分化功能的相反长期作用可能是由其对原癌基因表达的不同初始作用介导的,特别是对Jun家族成员的作用。